¼¼°èÀÇ µ¿¹°¿ë ÇÇºÎ¾à ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®(ÀûÀÀÁõº°, À¯Çüº°, µ¿¹°À¯Çüº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, Áö¿ªº°), ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Veterinary Dermatology Drugs Market Size, Share & Trends Analysis Report By Indication, By Type, By Animal Type, By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1632656
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,443,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,862,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,700,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

µ¿¹°¿ë ÇÇºÎ¾à ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è µ¿¹°¿ë ÇÇºÎ¾à ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 295¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇϸç 2025³âºÎÅÍ 2030³â±îÁö CAGRÀº 9.60%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀ» °ßÀÎÇÏ´Â °ÍÀº ¹Ý·Áµ¿¹°¿¡ ´ëÇÑ ÁöÃâ Áõ°¡, ¹Ý·Áµ¿¹°ÀÇ Àΰ£È­, °ßÁ¶ÇÑ R&D ÆÄÀÌÇÁ¶óÀÎ, ½ÅÁ¦Ç° Ãâ½Ã, ÇǺΠÁúȯ À¯Çà, ÁÖ¿ä ±â¾÷ÀÇ ³ë·Â µîÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 6¿ù Zoetis´Â Apoquel Chewable(°³ ¾Ë·¹¸£±â¼º °¡·Á¿òÁõ ¹× ¿°ÁõÀ» ¾ïÁ¦ÇÏ´Â ±¹³» ÃÖÃÊÀÇ À¯ÀÏÇÑ ¾ÃÀ» ¼ö ÀÖ´Â ÀǾàǰ)ÀÇ FDA Àΰ¡¸¦ ÃëµæÇß½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ȸ»çÀÇ Æ÷Æ®Æú¸®¿À°¡ È®´ëµÇ°í ¼ºÀå ¸ñÇ¥°¡ ´Þ¼ºµÇ¾ú½À´Ï´Ù.

2020³âºÎÅÍ 2022³â±îÁö COVID-19 ÆÒµ¥¹Í°ú °Å½Ã°æÁ¦ÀÇ ¿ªÇ³Àº ½ÃÀå¿¡ ±àÁ¤ÀûÀÌ°í ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ¿©±â¿¡´Â °æ¿µ ¹®Á¦, °ø±Þ¸Á È¥¶õ, ¼öÀÇÇÐ Á¢±Ù Á¦ÇÑ, ¹Ý·Áµ¿¹° »çÀ° ±ÞÁõ, ¿ø°Ý ÀÇ·á ä¿ë, ¹Ý·Áµ¿¹° º¸Çè º¸±Þ È®´ë µîÀÌ Æ÷ÇԵ˴ϴÙ. ¿¹¸¦ µé¾î VimianÀº 2022³â 1ºÐ±âÀÇ ¼ºÀåÀÌ µÐÈ­µÈ °ÍÀ¸·Î 4ºÐ±â ÃâÇÏ·® º¯µ¿À¸·Î ÇǺΰú Àü¹®ÀÇÇÐ ºÐ¾ß¿¡¼­ º¸°íÇß½À´Ï´Ù. 2022³â 3ºÐ±â¿¡´Â ȸ»ç´Â ÇǺΰú ¹× Àü¹® ÀÇ·á ºÐ¾ß¿¡¼­ °­·ÂÇÑ ¼ºÀåÀ» º¸°íÇß½À´Ï´Ù. ÇÑÆí Zoetis´Â 2021³â 2ºÐ±â, 3ºÐ±â, 4ºÐ±â¿¡ ÇǺΰú Á¦Ç°À» Æ÷ÇÔÇÑ ÀζóÀÎ Æ÷Æ®Æú¸®¿À¿¡¼­ °¢°¢ 14%, 3%, 9%ÀÇ ¼ö·® ¼ºÀåÀ» º¸¿´½À´Ï´Ù. ±×·¯³ª 2022³â¿¡´Â ZoetisÀÇ ÇǺΰú Á¦Ç° Æ÷Æ®Æú¸®¿À ÆÇ¸Å·®ÀÌ ¸Å ºÐ±â 1-2% Áõ°¡Çß½À´Ï´Ù.

µ¿¹°¼º ÇǺΰúÀÇ ¿µ¿ª¿¡¼­ Áö¼ÓÀûÀÎ R&D ³ë·ÂÀ¸·Î ´õ¿í È¿°úÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î Á¦ÇüÀÌ °³¹ßµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦ÇüÀº Á¾Á¾ Åõ¿©°¡ ¿ëÀÌÇϸç, ¹Ý·Áµ¿¹°¿¡ ½Å¼ÓÇÑ ±¸Á¦¸¦ Á¦°øÇϰí, º¹¾à ÄÄÇöóÀ̾𽺸¦ º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷¿¡ ÀÇÇÑ ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡´Â R&D ÆÄÀÌÇÁ¶óÀÎÀ» ÃËÁøÇÏ°í ½ÃÀå¿¡¼­ ½ÅÁ¦Ç° Ãâ½Ã¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 5¿ù, Dechra Pharmaceuticals PLC´Â ½ºÄÚÆ²·£µåÀÇ ILC Therapeutics¿Í Á¦ÈÞÇÏ¿© °³ ¾ÆÅäÇÇ ÇǺο° Ä¡·áÁ¦·Î ÈÄÀÚÀÇ Caniferon Á¦Ç°À» ¿¬±¸ °³¹ßÇß½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ±â¾÷ÀÇ Á¦Ç° ÆÄÀÌÇÁ¶óÀÎÀÌ ´õ¿í Çâ»óµÇ¾ú½À´Ï´Ù.

µ¿¹°¿ë ÇǺΰú ¾à ½ÃÀå : ºÐ¼® °³¿ä

¸ñÂ÷

Á¦1Àå ºÐ¼® ¹æ¹ý¡¤¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå µ¿¹°¿ë ÇÇºÎ¾à ½ÃÀå : º¯µ¿ ¿äÀΡ¤°æÇ⡤¹üÀ§

Á¦4Àå µ¿¹°¿ë ÇÇºÎ¾à ½ÃÀå : ÀûÀÀÁõº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå µ¿¹°¿ë ÇÇºÎ¾à ½ÃÀå : À¯Çüº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå µ¿¹°¿ë ÇÇºÎ¾à ½ÃÀå : µ¿¹°À¯Çüº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå µ¿¹°¿ë ÇÇºÎ¾à ½ÃÀå : Åõ¿© °æ·Îº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå µ¿¹°¿ë ÇÇºÎ¾à ½ÃÀå : À¯Åë ä³Îº° Àü¸Á, ÃßÁ¤, ¿¹Ãø

Á¦9Àå µ¿¹°¿ë ÇÇºÎ¾à ½ÃÀå :Áö¿ªº° Àü¸Á, ÃßÁ¤, ¿¹Ãø

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå Áß¿äÇÑ Æ÷ÀÎÆ®

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Veterinary Dermatology Drugs Market Growth & Trends:

The global veterinary dermatology drugs market size is expected to reach USD 29.51 billion by 2030, registering a CAGR of 9.60% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by increasing pet expenditure, humanization of pets, robust R&D pipeline, launch of new products, the prevalence of dermatologic conditions, and initiatives by key companies. For example, in June 2023, Zoetis received FDA clearance for Apoquel Chewable- the country's first and only chewable pharmaceutical for controlling allergic itch and inflammation in dogs. This expanded the company's portfolio and supported its growth objectives.

The COVID-19 pandemic and macroeconomic headwinds from 2020 to 2022 had both positive and negative impacts on the market. This included operational challenges, supply chain disruption, limited access to veterinary care, spike in pet adoption, adoption of telemedicine, and increased penetration of pet insurance. Vimian for instance, reported dampened growth during Q1 2022 in its dermatology & specialty care segments due to volatility in shipments between quarters. By Q3 2022, the company reported robust growth in Dermatology & Specialty Care segments. Zoetis on the other hand witnessed volume growth of 14%, 3%, and 9% from in-line portfolio, including its dermatology products during Q2, Q3, and Q4 2021 respectively. In 2022, however, Zoetis reported 1-2% volume growth in its dermatology portfolio every quarter.

Ongoing research and development efforts in the field of veterinary dermatology have led to the creation of more effective and user-friendly drug formulations. These formulations are often easier to administer and can provide quicker relief for pets, ensuring medication compliance. Growing initiatives by key market players is expected to propel the R&D pipeline and promote the launch of new products in the market. In May 2023, Dechra Pharmaceuticals PLC for example, partnered with ILC Therapeutics in Scotland to research and develop the latter's Caniferon product for the treatment of atopic dermatitis in dogs. This added to the company's product pipeline.

Veterinary Dermatology Drugs Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Veterinary Dermatology Drugs Market Variables, Trends, & Scope

Chapter 4. Veterinary Dermatology Drugs Market: Indication Estimates & Trend Analysis

Chapter 5. Veterinary Dermatology Drugs Market: Type Estimates & Trend Analysis

Chapter 6. Veterinary Dermatology Drugs Market: Animal Type Estimates & Trend Analysis

Chapter 7. Veterinary Dermatology Drugs Market: Route of Administration Estimates & Trend Analysis

Chapter 8. Veterinary Dermatology Drugs Market: Distribution Channel Estimates & Trend Analysis

Chapter 9. Veterinary Dermatology Drugs Market: Regional Estimates & Trend Analysis

Chapter 10. Competitive Landscape

Chapter 11. Key Takeaways

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â